Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Clomethiazole (Distraneurin) on CYP2E1 Activity and Liver Parameters during Alcohol Detoxification – Pilot Study
2012-005730-11Phase 2Completed
- Sponsor
- Krankenhaus Salem
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of clomethiazole in alcoholic liver disease (ALD), sponsored by Krankenhaus Salem. Primary endpoint: Changes in ASAT. Started Nov 2014; status: completed.
02
Drugs
clomethiazole
03
Conditions
alcoholic liver disease (ALD)
Beyond the preview
Go deeper on 2012-005730-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005730-11.